XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E953. A total of 3 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,322 | -59.8% | 7,700 | -43.4% | 0.00% | – |
| Q2 2023 | $35,632 | +385.8% | 13,600 | +202.2% | 0.00% | – |
| Q1 2023 | $7,335 | -1.5% | 4,500 | -19.6% | 0.00% | – |
| Q4 2022 | $7,448 | -46.8% | 5,600 | -36.4% | 0.00% | – |
| Q3 2022 | $14,000 | +27.3% | 8,800 | +22.2% | 0.00% | – |
| Q2 2022 | $11,000 | +120.0% | 7,200 | +300.0% | 0.00% | – |
| Q1 2022 | $5,000 | -98.9% | 1,800 | -98.8% | 0.00% | – |
| Q4 2021 | $451,000 | – | 153,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 4,500 | $7,335 | 0.00% |
| SIMPLEX TRADING, LLC | 1,800 | $2 | 0.00% |